UK markets open in 2 hours 22 minutes

Achilles Therapeutics plc (ACHL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.10+0.03 (+0.42%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.07
Open7.07
Bid0.00 x 3200
Ask0.00 x 1200
Day's range6.85 - 7.25
52-week range5.45 - 18.95
Volume210,742
Avg. volume239,253
Market cap288.285M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-5.11
Earnings date09 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est19.83
  • Globe Newswire

    Achilles Therapeutics to join the Northern Alliance Advanced Therapy Treatment Centre consortium

    - Achilles’ platform will help support the consortium to address gaps in delivering cell therapies to patients - LONDON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that it has joined the Northern Alliance for Advanced Therapies Treatment Centre (NA-ATTC) consortium. The NA-ATTC consortium is funded by Innovate UK, the government’s innovation age

  • Globe Newswire

    Achilles Therapeutics to Present at Upcoming Scientific Congresses

    LONDON, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, will present an oral presentation at the 2021 European Society for Gene and Cell Therapy (ESGCT) Congress being held in a virtual format from October 19-22, 2021, and two posters at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting being held in a hybrid format from November 10-14, 2021 online

  • Simply Wall St.

    Here's What Achilles Therapeutics plc's (NASDAQ:ACHL) Shareholder Ownership Structure Looks Like

    The big shareholder groups in Achilles Therapeutics plc ( NASDAQ:ACHL ) have power over the company. Generally...